CN1775799A - C22 steroid compounds and their synthesizing method - Google Patents

C22 steroid compounds and their synthesizing method Download PDF

Info

Publication number
CN1775799A
CN1775799A CN 200510111267 CN200510111267A CN1775799A CN 1775799 A CN1775799 A CN 1775799A CN 200510111267 CN200510111267 CN 200510111267 CN 200510111267 A CN200510111267 A CN 200510111267A CN 1775799 A CN1775799 A CN 1775799A
Authority
CN
China
Prior art keywords
compound
equivalent
solvent
hour
class
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510111267
Other languages
Chinese (zh)
Other versions
CN100358913C (en
Inventor
田伟生
朱伟明
许启海
王真
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Organic Chemistry of CAS
Yunnan Baiyao Group Co Ltd
Original Assignee
Shanghai Institute of Organic Chemistry of CAS
Yunnan Baiyao Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Organic Chemistry of CAS, Yunnan Baiyao Group Co Ltd filed Critical Shanghai Institute of Organic Chemistry of CAS
Priority to CNB2005101112679A priority Critical patent/CN100358913C/en
Publication of CN1775799A publication Critical patent/CN1775799A/en
Application granted granted Critical
Publication of CN100358913C publication Critical patent/CN100358913C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a C22 steroid compound and the method to compound. It is easy to be compounded, and is suited for manufacturing. It uses 17-alpha-hydroxyl radical-steroid lactone, which is the important intermediate for compounding steroid compound containing 17-hydroxyl radical. And it also has certain biological activity.

Description

One class C22 steroidal compounds and synthetic method thereof
Technical field
This patent relates to a class C22 steroidal compounds and a synthetic method thereof.Utilize the existing technology of contriver, the natural steroid sapogenines of degrading is the steroidal lactone, utilizes method of the present invention further to transform again, can obtain a series of C22 steroidal compounds, comprising target compound 17-Alpha-hydroxy-steroidal lactone.
Background technology
Have the alpha-hydroxy steroidal compounds of 17-and all have unique biological activity and pharmaceutical use, as marine natural product Cephalostatine (Cephalostatine) (referring to J.Chem.Soc., Chem..Commun., 1988,865; Ibid, 1988,1440), natural product OSW-1 (OSW-1) is (referring to Bioorg.﹠amp; Med.Chem.Lett, 1997,7,633) and the inclined to one side promise saponin in Yunnan white powder and the Sichuan baiyao series product (referring to pharmaceutical analysis magazine, 1997,17,153; The pharmaceutical analysis magazine, 1991,11,90; China Medicine University's journal, 1989,20,251).Although the synthetic of these compounds had bibliographical information, seek succinct more reasonably synthetic route and remain the target that synthetic chemistry man is pursued.
Figure A20051011126700061
17-Alpha-hydroxy-steroidal lactone can be used for the steroidal compounds of the synthetic above-mentioned 17-of containing hydroxyl, and 17-Alpha-hydroxy-steroidal lactone compound itself also has biological activity (CN 200510030831.4) preferably, therefore has good application prospects.People such as Tian Weisheng are devoted for years to the reasonable utilization research in the resource compound, the particularly reasonable utilization of steroid sapogenines, the degradation of steroid sapogenin that they have developed a kind of cleaning is the method (CN00127974.2) of steroidal lactone, has developed a kind of method that the steroidal lactone is 17-hydroxyl-steroidal lactone that transforms on this basis.
Summary of the invention
The purpose of this invention is to provide a class C22 steroidal compounds.
Another object of the present invention provides the synthetic method of a class C22 steroidal compounds.
17-Alpha-hydroxy-steroidal lactone involved in the present invention has following structural formula:
Y is H 2Perhaps O; R 1Be H, OH, OMOM, OBn, OTHP, OAc, OMs, OTs, OBz, OPiv, OTMS, OTES, OTBS or OTBDPS; R 2Be H, OH, OMOM, OBn, OTHP, OAc, OMs, OTs, OBz, OPiv, OTMS, OTES, OTBS, OTBDPS or X; R 3Be H, OH, OMOM, OBn, OTHP, OAc, OMs, OTs, OBz, OPiv, OTMS, OTES, OTBS, OTBDPS or X; Perhaps R 2And R 3Become carbonyl; R 4Be H, OH, OMe, OEt, OMOM, OBn, OTHP, OAc, OMs, OTs, OBz, OPiv, OTMS, OTES, OTBS, OTBDPS or X; R 5Be OH, OTMS or X; R 6Be OH, OMs, OTs or X; Perhaps R 5And R 6Become 16, the two keys of 17-; R 7Be H, OH or X; Perhaps R 5And R 7Become 16, the 17-epoxy; R 8For H, OH,, OMe, OEt, OMOM, OBn, OTHP, OAc, OMs, OTs, OBz, OPiv, OTMS, OTES, OTBS, OTBDPS or X; Perhaps R 6And R 8Become oxo bridge;
When Y is O, R 7Be H, R 6And R 8Become oxo bridge, R 3Be H, and R 4During for H, R 2Can not be H, OH, OMOM, OAc, OTBS, OTBDPS or X.
Wherein, MOM is a methoxyl methyl, and Bn is a benzyl; THP is a THP trtrahydropyranyl, and Ac is an ethanoyl, and Ms is a methylsulfonyl; Ts is a p-toluenesulfonyl; Bz is a benzoyl, and Piv is a pivaloyl group, and TMS is trimethyl silicon based; TES is that triethyl is silica-based; TBS is that tertiary butyl dimethyl is silica-based, and TBDPS is that tert-butyl diphenyl is silica-based, and X is a halogen.
The synthetic method of C22 steroidal compounds of the present invention is as follows:
Figure A20051011126700081
Each group described as defined above, Ac is an ethanoyl.Wherein, in the compound 7, work as R 2Be H and R 3During for H,
Figure A20051011126700082
Can not for Or
Figure A20051011126700084
1): compound 1 is dissolved in the aprotic solvent, adds reductive agent (0.5 equivalent-3 equivalent) ,-78 ℃ were reacted 0.5 hour to 24 hours to the temperature that refluxes, get compound 2; Described reductive agent can be sodium borohydride (NaBH 4), sodium cyanoborohydride (NaBH 3CN), POTASSIUM BOROHYDRIDE (KBH 4), lithium borohydride (LiBH 4), Li-Al hydrogen (LiAlH 4) or diisobutyl aluminium hydride (DIBALH).
2): compound 2 is dissolved in the organic solvent, adds diacetyl oxide or Acetyl Chloride 98Min. (0.5 equivalent-6 equivalent) ,-78 ℃ were reacted 0.5 hour to 24 hours to reflux temperature; Add SULPHURYL CHLORIDE (1 equivalent-6 equivalent) then, heat to make in 0.5 hour to 24 hours and react completely, compound 3; Described organic solvent is non-protonic solvent, nitrogenous organic base or their mixed solvent; Described nitrogenous organic base is 1,8-diazabicylo [5,4,0] 11-7-alkene (DBU), pyridine, 4-Dimethylamino pyridine (DMAP), bipyridine, lutidine (lutidine), trimethylpyridine (collidine) or have primary amine, secondary amine or the tertiary amine of C1-18 alkyl; Described sulfonic acid acyl chlorides can be methylsulfonyl chloride, Tosyl chloride or trifluoromethanesulfchloride chloride.
3): compound 3 is dissolved in the polar solvent, and adding removes protecting group reagent (1 equivalent-6 equivalent), and-78 ℃ were reacted 0.5 hour to 24 hours to reflux temperature, get compound 4; Removing protecting group reagent can be to comprise the monovalence of sodium bicarbonate, saleratus, yellow soda ash, salt of wormwood, cesium carbonate, lime carbonate, lithium hydroxide, sodium hydroxide, potassium hydroxide, calcium hydroxide or oxyhydroxide, carbonate or the supercarbonate of divalent metal.
4): compound 4 is dissolved in the organic solvent, adds oxygenant (1 equivalent-9 equivalent) ,-78 ℃ were reacted 0.5 hour to 72 hours to reflux temperature, get compound 5; Wherein, recommending organic solvent can be dimethyl formamide (DMF), hexamethylphosphoramide (HMPT), the trimethyl carbinol or methylene dichloride; Oxygenant can be Manganse Dioxide, potassium manganate, potassium permanganate, chromic anhydride, Sodium chromate, chromic acid pyridinium salt, clorox, Textone or potassium chlorite.
5): compound 5 is dissolved in the non-protonic solvent, adds epoxidation reagent (1 equivalent-6 equivalent) ,-78 ℃ were reacted 0.5 hour to 6 hours to reflux temperature, get compound 6; Epoxidation reagent can be Peracetic Acid, metachloroperbenzoic acid (MCPBA), hydrogen peroxide, peroxy trifluoroacetic acid or peroxy propanone (DMDO).
6): compound 6 is dissolved in the organic solvent, adds appropriate bases (1 equivalent-9 equivalent) and hydrogen peroxide (0.5 equivalent-10 equivalent), reaction is 0.5 hour to 24 hours under 0 ℃ of-90 ℃ of temperature, gets compound 7; Recommending organic solvent can be alcoholic solvent, acetone or tetrahydrofuran (THF); Alkali can be oxyhydroxide, carbonate, supercarbonate, acetate or nitrogenous organic base.
Non-protonic solvent described in the above-mentioned reaction is CH 2Cl 2, CHCl 3, CCl 4, tetrahydrofuran (THF) (THF) or ether; Described polar solvent is acetone, acetonitrile, methyl alcohol, ethanol, propyl alcohol, Virahol, butanols, the trimethyl carbinol, trichloromethane, methylene dichloride or water.
In order to understand content of the present invention better, be example with the compound of following structure:
Figure A20051011126700091
The method of above-mentioned synthetic 17-Alpha-hydroxy steroidal lactone is comparatively easy, is fit to industrial production, and the guarantee of amount is provided for the widespread use (the synthetic application and active the application) of 17-Alpha-hydroxy steroidal lactone.
Embodiment
To help to understand the present invention by following embodiment, but not limit content of the present invention.EA represents ultimate analysis among the embodiment, and Calcd represents calculated value, and Fould represents measured value.
Starting compound 1a that the present invention uses and 1b are by the method synthetic (CN 00127974.2) of document.
Embodiment 1 compound 2a's is synthetic
Figure A20051011126700102
In the 500mL exsiccant there-necked flask, add 2.17g LiAlH 4(0.057mol), 60mL anhydrous tetrahydro furan.Other gets 17.8 steroidal lactone 1a (0.05mol), and it is dissolved in the 100mL anhydrous tetrahydro furan, is added drop-wise under the nitrogen protection in the above-mentioned solution, and stirring at room 6h, TLC follow the tracks of reaction to complete (1: 1 n-C 6H 14-AcOEt launches).Reaction finishes, and carefully and lentamente drips 2mL water, the 2mL 2M NaOH aqueous solution and 2mL water according to the order of sequence, adds anhydrous magnesium sulfate, and placement is spent the night.Filtration under diminished pressure, and with ethyl acetate washing leaching cake 3 times, decompression and solvent recovery, solid crude product 19g.Rapid column chromatography separates (2: 1 n-C 6H 14-AcOEt wash-out), get powdery 16 β, 22-glycol 2a 17.0g (95.0% productive rate).
Compound 2a:
IR?ν max KBr(cm -1):3363(OH),1099,1037.
1H-NMR(300MHz,CDCl 3)δ:4.40(ddd,1H,J=4.5,7.5,7.8Hz,H-16α),3.59(d,2H,J=5.7Hz,H-22),3.32(s,3H,MeO),2.78(dd,‘t’like,1H,J=2.7Hz,H-6α),1.03(s,3H,H-19),0.97(d,3H,J=5.7Hz,H-21),0.95(s,3H,H-18),0.66(dd,1H,J=4.1,7.8Hz,H-4β),0.44(dd,1H,J=4.8,7.8Hz,H-4α).
13C-NMR(75MHz,CDCl 3)δ:33.2(t,C-1),24.9(t,C-2),21.6(d,C-3),13.4(t,C-4),35.3(s,C-5),82.3(d,C-6),34.8(t,C-7),30.0(d,C-8),47.9(d,C-9),43.3(s,C-10),22.4(t,C-11),40.5(t,C-12),43.0(s,C-13),54.2(d,C-14),32.5(t,C-15),72.6(d,C-16),62.2(d,C-17),13.0(q,C-18),19.2(q,C-19),35.6(d,C-20),16.9(q,C-21),70.6(t,C-22),56.5(q,MeO-).
EIMS(70eV)m/z(%):362(M +,9),348(55),330(29),307(86),290(52),253(44),213(41),159(42),145(59),131(60),121(49),105(78),91(90),79(72),43(100).
Anal.calcd.for?C 23H 38O 3(%):C,76.20;H,10.56.Found:C,76.13;H,10.57.
Embodiment 2 compound 2aa's is synthetic
In the 250mL exsiccant there-necked flask, put into the stirring magneton, 2.53g compound 2a (7mmol) adds the 50mL anhydrous methylene chloride, and stirring makes molten.Add 4mL anhydrous pyridine (0.049mole) and 570uL AcCl (8mmol), stir 3~5h in the nitrogen atmosphere, TLC follows the tracks of reaction to complete (2: 1 n-C 6H 14-AcOEt launches).Reaction finishes, and adds the 50mL frozen water, tells organic layer; Water layer with the 50mL dichloromethane extraction once merges organic layer.Use saturated CuSO successively 4The aqueous solution, water and saturated sodium-chloride water solution respectively wash 2 times, anhydrous sodium sulfate drying, and decompression and solvent recovery gets oily matter 2.9g, is foaming shape solid during the oil pump drying under reduced pressure.Rapid column chromatography separates (6: 1 n-C 6H 14-AcOEt wash-out), get the monoacylated product 2aa of oily 2.36g (83% productive rate) and diacetyl product 2ab 0.3g (9.8% productive rate).
Compound 2aa:
IR?ν max KBr(cm -1):3500(OH),1727(C=O),1247,1091,1033,917,734.
EIMS(70eV)m/z(%):404(M +,16),356(100),350(63),296(78),253(43),43(32).
1H-NMR(300MHz,CDCl 3)δ:4.35(dd,H,J=3.0,10.8Hz,H-22b),4.34(dd,1H,J=3.3,7.6Hz,H-16α),3.67(dd,H,J=7.8,10.8Hz,H-22a),3.31(s,3H,MeO),2.77(dd,‘t’like,1H,J=2.6Hz,H-6α),2.07(s,3H,Ac-),1.08(d,3H,J=6.9Hz,H-21),1.02(s,3H,H-19),0.95(s,3H,H-18),0.64(dd,‘t’like,1H,J=3.9,5.1Hz,H-4β),0.42(dd,1H,J=4.9,7.9Hz,H-4α).
Compound 2ab:
1H-NMR(300MHz,CDCl 3)δ:5.10(ddd,1H,J=4.0,7.5,7.5Hz,H-16α),4.08(dd,1H,J=3.1,10.6Hz,H-22b),3.68(dd,1H,J=7.0,10.6Hz,H-22a),3.30(s,3H,MeO),2.76(dd,‘t’like,1H,J=2.6Hz,H-6α),2.25(dq,3.6,6.6Hz,H-20),2.04(s,3H,Ac-1),2.03(s,3H,Ac-2),1.05(d,3H,J=6.6Hz,H-21),1.02(s,3H,H-19),0.94(s,3H,H-18),0.64(dd,‘t’like,1H,J=4.6Hz,H-4β),0.43(dd,1H,J=5.0,8.0Hz,H-4α).
13C-NMR(75MHz,CDCl 3)δ:33.1(t,C-1),24.8(t,C-2),21.4(d,C-3),12.9(t,C-4),35.2(s,C-5),82.0(d,C-6),34.6(t,C-7),30.1(d,C-8),47.7(d,C-9),43.3(s,C-10),22.2(t,C-11),39.8(t,C-12),42.9(s,C-13),54.0(d,C-14),29.9(t,C-15),74.8(d,C-16),55.9(d,C-17),12.8(q,C-18),19.2(q,C-19),35.1(d,C-20),16.4(q,C-21),68.7(t,C-22),56.5(q,MeO-),171.0(s),170.6(s),21.2(q)and?20.8(q)(two?acetyls).
Embodiment 3 compound 2ac's is synthetic
In 250mL exsiccant there-necked flask, add 2.02g compound 2aa (5mmol), 50mL anhydrous methylene chloride, stirring makes molten.Add 3mL anhydrous pyridine (37mmol) and 770uL MsCl (10mmol), stir 18h in the nitrogen atmosphere, TLC follows the tracks of reaction to complete (3: 1 n-C 6H 14-AcOEt launches).Reaction finishes, and is poured in the 50mL frozen water, tells organic layer; Water layer again with the 50mL dichloromethane extraction once merges organic layer.Use saturated CuSO successively 4The aqueous solution, water and saturated sodium-chloride water solution respectively wash 2 times, anhydrous sodium sulfate drying, and decompression and solvent recovery gets oily matter 4.2g.Rapid column chromatography separates (4: 1 n-C 6H 14-AcOEt wash-out), get oily sulfonylation product 2ac 1.63g (68% productive rate) and 16 alpha-chloro product 2ad 0.65g (31% productive rate).Compound 2ac:
1H-NMR(300MHz,CDCl 3)δ:5.17(ddd,1H,J=4.2,7.5,7.8Hz,H-16α),4.25(dd,H,J=2.7,10.8Hz,H-22b),3.90(dd,H,J=7.3,10.8Hz,H-22a),3.33(s,3H,MeO),3.04(s,3H,Ms),2.78(dd,‘t’like,1H,J=2.7Hz,H-6α),2.07(s,3H,Ac-),1.07(d,3H,J=6.9Hz,H-21),1.03(s,3H,H-19),0.95(s,3H,H-18),0.66(dd,‘t’like,1H,J=4.2Hz,H-4β),0.45(dd,1H,J=4.8,7.8Hz,H-4α).
Compound 2ad:
IR?ν max KBr(cm -1):1742(C=O),1243,1089,1037.
1H-NMR(300MHz,CDCl 3)δ:4.31(dd,1H,J=4.2,11.2Hz,H-22b),4.11(ddd,1H,J=1.8,6.0,6.0Hz,H-16β),3.96(dd,1H,J=7.2,11.2,H-22a),3.33(s,3H,MeO),2.79(dd,‘t’like,1H,J=3.0Hz,H-6α),1.05(d,3H,J=6.6Hz,H-21),1.02(s,3H,H-19),0.77(s,3H,H-18),0.67(dd,‘t’like,1H,J=4.5Hz,H-4β),0.46(dd,1H,J=5.2,8.0Hz,H-4α).
13C-NMR(75MHz,CDCl 3)δ:33.2(t,C-1),24.9(t,C-2),21.2(d,C-3),13.1(t,C-4),35.2(s,C-5),82.0(d,C-6),34.9(t,C-7),29.6(d,C-8),47.7(d,C-9),43.3(s,C-10),22.4(t,C-11),34.1(t,C-12),45.1(s,C-13),52.9(d,C-14),38.2(t,C-15),64.9(d,C-16),62.5(s,C-17),13.3(q,C-18),19.2(q,C-19),39.9(d,C-20),17.4(q,C-21),68.9(t,C-22),56.6(q,6-MeO),171.2(s)and?21.0(q)(22-Ac).
EIMS(70eV)m/z(%):424(M ++2,5),422(M +,15),409(12),407(36),392(11),390(36),367(21),367(63),329(7),289(11),271(7),159(12),145(13),133(16),119(14),105(28),91(31),79(27),67(17),55(21),43(100).
HRMS(EI)calcd.for?C 25H 39O 3Cl?422.2588,Found?422.2570.
Embodiment 4 compound 3a's is synthetic
(1) synthetic by 2ac
Figure A20051011126700141
In 100mL exsiccant there-necked flask, add 2.5g compound 2ac (5.2mmol), 10mL anhydrous pyridine, stirring makes molten.Add 1.28g DMAP (10.4mmol), in 90-100 ℃ of stirring reaction 12h, TLC follows the tracks of (2: 1 n-C that react completely in the nitrogen atmosphere 6H 14-AcOEt launches), add 200mL CH 2Cl 2, wash with water once, again with saturated CuSO 4The aqueous solution, water and saturated sodium-chloride water solution respectively wash 2 times, anhydrous sodium sulfate drying, and decompression and solvent recovery gets oily matter 1.68g.Rapid column chromatography separates (19: 1 n-C 6H 14-AcOEt wash-out), get oily 3a 1.20g (60% productive rate, 34%from 2a in three steps).
(2) synthetic by 2ad
Figure A20051011126700142
In 100mL exsiccant there-necked flask, add 2ad 1.22g (2.89mmol), 10mL dry DMF, stirring makes molten.Add 0.61g LiBr (5.81mmol) and 0.64g Li 2CO 3(8.65mmol), slowly heat up in the nitrogen atmosphere, prior to 70-90 ℃ of stirring reaction 3h, again in about 110 ℃ react completely (TLC tracking, 2: 1n-C 6H 14-AcOEt launches), add 80mL CH 2Cl 2, water and saturated sodium-chloride water solution respectively wash 2 times, anhydrous sodium sulfate drying, and decompression and solvent recovery, the crude product rapid column chromatography separates (19: 1 n-C 6H 14-AcOEt wash-out), get oily 3a 0.83g (75.0% productive rate).
Compound 3a:
1H-NMR(300MHz,CDCl 3)δ:5.38(dd,‘t’like,1H,J=1.5Hz,H-16),4.10(dd,H,J=5.8,10.8Hz,H-22b),3.92(dd,H,J=8.4,10.8Hz,H-22a),3.33(s,3H,MeO),2.78(dd,‘t’like,1H,J=2.6Hz,H-6α),2.03(s,3H,Ac-),1.04(d,3H,J=6.6Hz,H-21),1.03(s,3H,H-19),0.80(s,3H,H-18),0.67(dd,‘t’like,1H,J=4.4Hz,H-4β),0.44(dd,1H,J=5.0,8.1Hz,H-4α).
13C-NMR(75MHz,CDCl 3)δ:33.1(t,C-1),24.9(t,C-2),21.4(d,C-3),13.0(t,C-4),35.3(s,C-5),82.3(d,C-6),35.0(t,C-7),29.6(d,C-8),48.6(d,C-9),43.5(s,C-10),22.3(t,C-11),31.2(t,C-12),47.3(s,C-13),57.1(d,C-14),29.0(t,C-15),122.5(d,C-16),157.0(s,C-17),16.5(q,C-18),19.2(q,C-19),31.4(d,C-20),18.7(q,C-21),68.6(t,C-22),56.6(q,6-MeO),171.2(s)and?21.0(q)(22-Ac).
EIMS(70eV)m/z(%):371(M +-15,4),327(14),312(21),295(48),280(100),254(61),174(52),159(42),145(65),131(51),105(64),91(63),43(79).
Embodiment 5 compound 4a's is synthetic
Figure A20051011126700151
In 100mL egg shape flask, add compound 3a 2.32g (6mmol), methyl alcohol 60mL, 0.68g KOH (12mmol) and water 5mL, the stirring and refluxing reaction, TLC follows the tracks of reaction (3: 1 n-C extremely fully 6H 14-AcOEt launches).Reaction finishes, and the most of methyl alcohol of pressure reducing and steaming adds entry 50mL, uses the 100mL ethyl acetate extraction.Organic layer respectively washs 2 times with water and saturated sodium-chloride water solution, anhydrous sodium sulfate drying, and decompression and solvent recovery gets oily matter 2.6g.Rapid column chromatography separates (4: 1 n-C 6H 14-AcOEt wash-out), get hydrolysate 4a 2.02g (97% productive rate).
Compound 4a:
1H-NMR(300MHz,CDCl 3)δ:5.41(dd,‘t’like,1H,J=1.6Hz,H-16),3.58(dd,‘t’like,2H,J=7.2,10.2Hz,H-22),3.35(s,3H,MeO),2.79(dd,‘t’like,1H,J=2.6Hz,H-6α),2.39(q,3H,J=6.6Hz),1.04(s,3H,H-19),1.02(d,3H,J=6.6Hz,H-21),0.85(s,3H,H-18),0.68(dd,‘t’like,1H,J=4.6Hz,H-4β),0.45(dd,1H,J=5.0,8.0Hz,H-4α).
Embodiment 6 compound 5a's is synthetic
In 50mL exsiccant there-necked flask, add 950mg compound 4a (2.76mmol), 7mL dry DMF, stirring makes molten.Add PDC reagent: (Py.H) + 2Cr 2O 7 2-(3.64g, 8.28mmol), stirring at room 4h, TLC follows the tracks of (5: 1 n-C 6H 14-AcOEt launches).After reaction is finished, contain the solid of chromium with the diatomite elimination, and use washed with dichloromethane, decompression and solvent recovery, gained oily matter separates (7: 1 n-C through rapid column chromatography 6H 14-AcOEt wash-out), the mixture 475mg (50.3%total productive rate) of oily 5a 400mg (40.4% productive rate) and three kinds of aldehyde 5aa, 5ab, 5ac.
In the 100mL there-necked flask, add mixture (7.6mmol), the 40mL trimethyl carbinol, 24mL water, the 4.0g KH of 2.6g aldehyde 2PO 4(28.9mmol), 1.50g Resorcinol (13.6mmol) and NaClO 2(80%purity) (2.7g, 11.4mmol), stirring at room 0.5~1h, TLC follows the tracks of (3: 1 n-C 6H 14-AcOEt launches).After reaction is finished,, respectively wash 2 times through water and saturated sodium-chloride water solution with twice washing of 60mL dichloromethane extraction, anhydrous sodium sulfate drying, decompression and solvent recovery gets oily solid (180mg) and separates (7: 2n-C through rapid column chromatography 6H 14-AcOEt wash-out), get oily 5a 1.56g (57.3% productive rate).
Compound 5a:
1H-NMR(300MHz,CDCl 3)δ:5.62(dd,‘t’like,1H,J=1.5Hz,H-16),3.36(s,3H,MeO),3.15(q,1H,J=6.9Hz,H-20),2.81(dd,‘t’like,1H,J=2.6Hz,H-6α),1.28(d,3H,J=6.9Hz,H-21),1.05(s,3H,H-19),0.87(s,3H,H-18),0.68(dd,‘t’like,1H,J=4.5Hz,H-4β),0.46(dd,1H,J=5.2,8.2Hz,H-4α).
EIMS(70eV)m/z(%):358(M +,23),343(88),326(24),311(83),303(95),285(39),253(69),159(31),145(32),131(40),119(49),105(82),91(100),79(65),67(37),55(46),43(52).
Compound 5aa:
1H-NMR(300MHz,CDCl 3)δ:9.45(d,1H,J=2.4Hz,H-22),5.46(dd,‘t’like,1H,J=1.5Hz,H-16),3.35(s,3H,MeO),3.03(q,1H,J=6.9Hz,H-20),2.80(dd,‘t’like,1H,J=2.7Hz,H-6α),1.19(d,3H,J=6.9Hz,H-21),1.05(s,3H,H-19),0.84(s,3H,H-18),0.67(dd,‘t’like,1H,J=4.3Hz,H-4β),0.45(dd,1H,J=5.2,8.2Hz,H-4α).
EIMS(70eV)m/z(%):342(M +,6),327(19),310(7),295(17),287(22),253(30),159(20),145(23),131(26),105(69),91(100),79(74),67(45),55(60),41(76).
Compound 5ab:
IR?ν max KBr(cm -1):2870(CHO),2250O,1728(C=O),1642(C=C),913,733.
1H-NMR(300MHz,CDCl 3)δ:10.45(s,1H,H-22),3.36(s,3H,MeO),2.84(dd,‘t’like,1H,J=3.0Hz,H-6α),1.95(s,3H,H-21),1.16(s,3H,H-18),1.07(s,3H,H-19),0.70(dd,‘t’like,1H,J=5.0Hz,H-4β),0.50(dd,1H,J=5.0,8.1Hz,H-4α).
EIMS(70eV)m/z(%):342(M +,4),341(14),329(8),317(10),301(12),281(14),253(11),214(15),199(15),159(12),145(10),121(14),105(24),91(38),84(92),71(37),57(56),49(100).
Compound 5ac:
IR?ν max KBr(cm -1):2870(CHO),2254,1717(C=O),1678(C=C),913,733.
1H-NMR(300MHz,CDCl 3)δ:10.37(s,1H,H-22),3.36(s,3H,MeO),2.84(dd,‘t’like,1H,J=2.7Hz,H-6α),2.12(s,3H,H-21),1.28(s,3H,H-18),1.07(s,3H,H-19),0.71(dd,‘t’like,1H,J=5.1Hz,H-4β),0.50(dd,1H,J=5.1,8.1Hz,H-4α).
EIMS(70eV)m/z(%):342(M +,24),341(99),324(29),301(100),281(15),273(26),214(13),199(16),159(20),145(21),123(35),105(46),91(66),79(49),55(30).
Embodiment 7 compound 6a's is synthetic
Figure A20051011126700171
In 50mL egg shape flask, add 1.0g 5a (2.71mmol), 30mL CH 2Cl 2, stirring makes molten.The frozen water cooling adds 802mg m-CPBA (70%purity) (3.25mmol) down, stirs 3~4h (rising to room temperature naturally), and TLC follows the tracks of (2: 1 n-C 6H 14-AcOEt launches).After reaction is finished, direct column chromatography for separation (3: 1n-C 6H 14-AcOEt wash-out), get oily 6a 653mg (64.4% productive rate).
Compound 6a:
1H-NMR(300MHz,CDCl 3)δ:4.13(dd,1H,J=6.9,14.2Hz,H-16β),3.35(s,3H,MeO),3.16(q,1H,J=6.9Hz,H-20),2.81(dd,‘t’like,1H,J=2.5Hz,H-6α),1.25(d,3H,J=6.9Hz,H-21),1.04(s,3H,H-19),0.94(s,3H,H-18),0.68(dd,‘t’like,1H,J=4.3Hz,H-4β),0.46(dd,1H,J=5.0,8.0Hz,H-4α).
EIMS(70eV)m/z(%):374(M +,5),359(11),342(21),324(12),319(23),301(10),269(11),145(19),131(22),119(24),105(51),91(73),79(60),67(47),55(96),41(100).
Embodiment 8 compound 7a's is synthetic
Figure A20051011126700181
In the 50mL there-necked flask, add 628mg epoxyeicosatrienoic acid 6a (1.68mmol), 15mL dehydrated alcohol, stirring makes molten.Add 710mg LiOHH 2O (16.8mmol) drips 30% hydrogen peroxide 5mL, and (H was added in the centre to reaction~24h under stirring also was warming up to 80 ℃ gradually 2O 22mL), TLC follows the tracks of (2: 1 n-C 6H 14-AcOEt launches).After reaction is finished, use saturated NaHSO 3Remove excessive hydrogen peroxide, add saturated NH 4The Cl aqueous solution is neutralized to acidity, tells organic phase, and with 100mL ethyl acetate extraction water once.Organic phase water and saturated sodium-chloride water solution respectively wash 2 times, anhydrous sodium sulfate drying, and decompression and solvent recovery, gained oily crude product separates (4: 1 n-C through rapid column chromatography 6H 14-AcOEt wash-out), get oily 17 alpha-hydroxy-2 2-carboxylic acid lactone 7a 500mg (79.6% productive rate).
Compound 7a:
IR?ν max KBr(cm -1):3474(OH),1755(C=O),1213,1096,1048,757.
1H-NMR(300MHz,CDCl 3)δ:4.49(dd,1H,J=4.8,8.1,H-16α),3.34(s,3H,MeO),2.79(dd,‘t’like,1H,J=2.8Hz,H-6α),2.74(q,1H,J=8.1Hz,H-20),1.30(d,3H,J=8.1Hz,H-21),1.05(s,3H,H-19),0.86(s,3H,H-18),0.68(dd,‘t’like,1H,J=4.2Hz,H-4β),0.47(dd,1H,J=5.5,8.5Hz,H-4α).
EIMS(70eV)m/z(%):374(M +,5),359(11),342(21),324(12),319(23),301(10),269(11),159(16),131(22),105(51),91(73),79(60),67(47),55(96),41(100).
HRMS(EI):calcd.for?C 23H 34O 4374.2457,Found?374.2437.
Embodiment 9 compound 2b's is synthetic
In 250mL exsiccant there-necked flask, add 420mg LiAlH 4(11.0mmol), the 30mL anhydrous tetrahydro furan, stir.In addition 5.0g lactone 1b (8.6mmol) is dissolved in the 50mL anhydrous tetrahydro furan, is added drop-wise in the nitrogen atmosphere in the above-mentioned suspension, stirring at room 6h, TLC follow the tracks of reaction to complete (1: 1 n-C 6H 14-AcOEt launches).Reaction finishes, and carefully and lentamente drips 1mL water, the 1mL 2M NaOH aqueous solution and 1mL water according to the order of sequence, adds anhydrous magnesium sulfate until generating white solid, and placement is spent the night.Filtration under diminished pressure, and with ethyl acetate washing leaching cake 3 times, decompression and solvent recovery, solid crude product 6g.Rapid column chromatography separates (2: 1 n-C 6H 14-AcOEt wash-out), get powdery 2b 4.8g (95% productive rate).
Compound 2b:
IR?ν max KBr(cm -1):3280(OH),1590,1472,1464(phenyl),1111,1089,865,821,701,507.
1H-NMR(300MHz,CDCl 3)δ:7.68(m,4H)and?7.39(m,6H)(phenyls?of?TBDPS),5.12(d,1H,J=5.4Hz,H-6),4.38(m,1H,H-16α),3.60(m,2H,H-22),3.51(m,1H,J=4.5,7.5,10.5Hz,H-3),2.79(m,1H,H-20),1.06(s,9H,tert-butyl),0.99(s,3H,H-19),0.96(d,3H,J=6.6Hz,H-21),0.90(s,3H,H-18).
EIMS(70eV)m/z(%):585(M +-1,0.2),529(M +-57,100),511(15),451(6),433(3),295(5),253(7),199(96),183(7),159(8),135(8),105(7),91(5).
Embodiment 10 compound 3b's is synthetic
Figure A20051011126700192
In 100mL exsiccant there-necked flask, add 3.0g glycol 2b (5.1mmol), 40mL anhydrous pyridine, stirring makes molten.Add Ac 2O 0.6mL (6.7mmol), in 35~40 ℃ of stirring reaction 48h, TLC follows the tracks of reaction to complete (2: 1 n-C in the nitrogen atmosphere 6H 14-AcOEt launches).Reaction finishes, and adds MsCl 0.8mL (10.2mmol) and 60mg DMAP (0.5mmol).Heat up 80~85 ℃ gradually, continue stirring reaction 15h, solution colour is deepened.Reaction finishes, be chilled to room temperature after, add 120mL AcOEt, successively water, saturated CuSO 4, water and saturated NaCl solution washed twice separately, through anhydrous Na 2SO 4After the drying, decompression and solvent recovery gets solid crude product 3.8g.Dry back rapid column chromatography separates (40: 1 n-C 6H 14-AcOEt wash-out), get powdery and eliminate product 3b 386mg (12.4% productive rate), 16 alpha-chloros-22-acetic ester 2bb 1.11g (33.8% productive rate) and 16 β-22-diacetyl product 2ba 1.46g (42.9% productive rate).
Figure A20051011126700201
In 100mL exsiccant egg shape flask, add 16 alpha-chloro product 2bb 324mg (0.5mmol), 111mg Li in the nitrogen atmosphere 2CO 3H 2O (1.5mmol), 105mg LiBr (1.0mmol), heavily steam DMF 5mL, open and stir.Be warming up to 130~140 ℃, TLC follows the tracks of reaction to complete (9: 1 n-C 6H 14-AcOEt launches).Reaction finishes, and adds AcOEt 60mL dilute reaction solution, and respectively washs 2 times with water and saturated sodium-chloride water solution, anhydrous sodium sulfate drying, and decompression and solvent recovery gets meal 0.31g.Rapid column chromatography separates (14: 1n-C 6H 14-AcOEt wash-out), get powdery 3b 290mg (95% productive rate).
Compound 3b:
IR?ν max KBr(cm -1):3034,1589,1475,1461(phenyl),1236,1112,1025,801,704,613,510.
1H-NMR(300MHz,CDCl 3)δ:7.68(d,4H,J=6.0Hz)and?7.38(d,6H,J=7.2Hz)(phenyls?of?TBDPS),5.39(br.s,1H,H-16α),5.14(d,1H,J=3.6Hz,H-6),4.11(dd,1H,J=6.0,10.5Hz,H-22a),3.93(dd,‘t’like,1H,J=10.5Hz,H-22b),3.53(m,1H,H-3),2.04(s,3H,acetyl),1.06(s,9H,tert-butyl),1.02(s,3H,H-19),1.04(d,3H,J=7.8Hz,H-21),0.76(s,3H,H-18).
EIMS(70eV)m/z(%):595(M +-15,1),553(M +-57,39),493(7),311?94),295(10),253(4),239(11),199(100),181(16),159(8),135(14),109(15),91(11).
Compound 2ba:
IR?ν max KBr(cm -1):3072,1590,1473(phenyl),1246,1111,1086,1027,742,703,612,509.
1H-NMR(300MHz,CDCl 3)δ:7.67(m,4H)and?7.38(m,6H)(phenyls?of?TPS),5.09(d,1H,J=4.2Hz,H-6),5.07(ddd,1H,J=4.3,7.9?7.9Hz,H-16α),4.07(dd,1H,J=3.5,10.9Hz,H-22a),3.65(dd,1H,J=6.9,10.9Hz,H-22b),3.50(m,1H,J=4.5,7.5,10.5Hz,H-3),2.03(s,6H,two?acetyls),1.05(s,9H,tert-butyl),0.98(s,3H,H-19),1.03(d,3H,J=6.6Hz,H-21),0.86(s,3H,H-18).
EIMS(70eV)m/z(%):613(M +-57,56),553(2),535(3),493(5),295(15),253(14),199(100),181(21),159(10),135(13),121(13),105(12),93(10).
Compound 2bb:
1H-NMR(300MHz,CDCl 3)δ:7.68(m,4H)and?7.38(m,6H)(phenyls?of?TPS),5.11(d,1H,J=5.4Hz,H-6),4.07(ddd,1H,J=2.5,6.6,6.9Hz,H-16β),4.30(dd,1H,J=3.7,11.2Hz,H-22a),3.94(dd,1H,J=6.7,11.2Hz,H-22b),3.54(m,1H,J=4.6,10.6Hz,H-3),2.05(s,3H,acetyls),1.06(s,9H,tert-butyl),0.97(s,3H,H-19),1.03(d,3H,J=6.9Hz,H-21),0.69(s,3H,H-18).
EIMS(70eV)m/z(%):592(M +-36,21),590(M +-38,48),554(13),511(6),494(9),296(15),253(14),199(100),181(16),159(9),135(9),121(8),105(9),93(7).
Embodiment 11 compound 2bc's is synthetic
Figure A20051011126700211
In 50mL exsiccant there-necked flask, add 0.59g glycol 2b (1.0mmol), 10mL anhydrous methylene chloride, stirring makes molten.Add 565 μ L anhydrous pyridines (7mmole) and 80 μ L AcCl (1.1mmol), stir 3~5h in the nitrogen atmosphere, TLC follows the tracks of reaction to complete (9: 1 n-C 6H 14-AcOEt launches).Reaction finishes, and adds the 10mL frozen water, tells organic layer; Water layer with the 20mL dichloromethane extraction once merges organic layer.Use saturated CuSO successively 4The aqueous solution, water and saturated sodium-chloride water solution respectively wash 2 times, anhydrous sodium sulfate drying, and decompression and solvent recovery, gained oily matter crude product separates (19: 1 n-C through rapid column chromatography 6H 14-AcOEt wash-out), get the monoacylated product 2bc of powdery 0.56g (88.9% productive rate).
Compound 2bc:
1H-NMR(300MHz,CDCl 3)δ:7.68(m,4H)and?7.38(m,6H)(phenyls?of?TPS),5.12(d,1H,J=4.8Hz,H-6),5.07(dd,2H,J=3.0,10.6Hz,H-16αand?H-22a),3.62(dd,1H,J=7.6,10.9Hz,H-22b),3.52(m,1H,J=4.5,7.5,10.5Hz,H-3),2.08(s,3H,acetyls),1.05(s,9H,tert-butyl),0.99(s,3H,H-19),1.07(d,3H,J=6.9Hz,H-21),0.89(s,3H,H-18).
Embodiment 12 compound 2bc's is synthetic
Figure A20051011126700221
In 100mL egg shape flask, add monoacetate 2bc 76mg (0.12mmol), CH 2Cl 25mL, stirring makes molten.Add anhydrous pyridine 0.61mL (0.78mmol), MsCl 20uL (0.26mmol) and DMAP 15mg (0.13mmol), the stirring at room reaction, TLC follows the tracks of reaction (3: 1 n-C extremely fully 6H 14-AcOEt launches).Reaction finishes, and adds entry 2mL, uses 20mL CH 2Cl 2Extraction.Organic layer respectively washs 2 times with water and saturated sodium-chloride water solution, anhydrous sodium sulfate drying, and decompression and solvent recovery, rapid column chromatography separates (4: 1 n-C 6H 14-AcOEt wash-out), get oily sulfonylation product 2bd 61mg (71.4% productive rate).
Compound 2bd:
1H-NMR(300MHz,CDCl 3)δ:7.65(m,4H)and?7.35(m,6H)(phenyls?of?TPS),5.06(d,1H,J=4.2Hz,H-6),5.14(ddd,1H,J=4.2,7.8?7.8Hz,H-16α),4.05(dd,1H,J=3.6,10.8Hz,H-22a),3.65(dd,1H,J=6.9,10.8Hz,H-22b),3.50(m,1H,J=4.5,7.5,10.5Hz,H-3),3.04(s,3H,Ms),2.03(s,3H,acetyl),1.05(s,9H,tert-butyl),0.98(s,3H,H-19),1.03(d,3H,J=6.6Hz,H-21),0.86(s,3H,H-18).
Embodiment 13 compound 4b's is synthetic
In 100mL egg shape flask, add compound 3b 320mg (0.563mmol), ethanol 20mL, 0.16g K 2CO 3(1.13mmol), stir.Temperature rising reflux, TLC are followed the tracks of reaction to complete (9: 1 n-C 6H 14-AcOEt launches).Reaction finishes, and pressure reducing and steaming ethanol adds saturated NH 4Cl aqueous solution 50mL uses the 60mL ethyl acetate extraction.Organic layer respectively washs 2 times with water and saturated sodium-chloride water solution, anhydrous sodium sulfate drying, and decompression and solvent recovery, the gained crude product separates (14: 1 n-C through rapid column chromatography 6H 14-AcOEt wash-out), get powdery 4b 266mg (90.0% productive rate).
Compound 4b:
1H-NMR(300MHz,CDCl 3)δ:7.68(m,4H)and?7.38(m,6H)(phenyls?of?TBDPS),5.42(br.s,H-16α),5.14(d,1H,J=5.1Hz,H-6),3.57(d,2H,J=6.3Hz,H-22),3.53(m,1H,H-3),1.06(s,9H,tert-butyl),1.02(s,3H,H-19),1.01(d,3H,J=6.3Hz,H-21),0.79(s,3H,H-18).
EIMS(70eV)m/z(%):511(M +-57,62),481(5),433(7),295(4),253(8),239(3),199(100),183(7),159(6),135(5),105(5),91(7).
Embodiment 14 compound 5ba's is synthetic
Figure A20051011126700231
In 50mL exsiccant there-necked flask, add enol 4b 100mg (0.176mmol), the anhydrous CH of 10mL 2Cl 2, stirring makes molten.Add Dess-Martin reagent 112mg (0.264mmol), stirring at room~6h, TLC follows the tracks of (9: 1 n-C 6H 14-AcOEt launches).Along with the carrying out of reaction, it is muddy that solution becomes.After reaction is finished, add 3~5mL 2M NaOH and be stirred to muddy solution becomes clarification.The 60mL ethyl acetate extraction, the ester layer respectively washs 2 times through water and saturated sodium-chloride water solution, anhydrous sodium sulfate drying, decompression and solvent recovery, the gained crude product separates (24: 1 n-C through rapid column chromatography 6H 14-AcOEt wash-out), get powdery 22-aldehyde 5ba 80mg (80.3% productive rate).
Compound 5ba:
1H-NMR(300MHz,CDCl 3)δ:9.44(d,1H,J=2.1Hz,H-22),7.68(m,4H)and?7.38(m,6H)(phenyls?of?TPS),5.46(br.s,H-16),5.13(d,1H,J=4.8Hz,H-6),3.54(m,1H,H-3),3.04(dq,1H,J=2.1,7.2Hz,H-20β),1.17(d,3H,J=7.2Hz,H-21),1.06(s,9H,ter-butylof?TPS),1.02(s,3H,H-19),0.78(s,3H,H-18).
Embodiment 15 compound 5b's is synthetic
(1) synthetic by 4b
In 50mL exsiccant there-necked flask, add 155mg enol 4b (0.29mmol), 2mL dry DMF, stirring makes molten.Add PDC reagent: (Py.H) + 2Cr 2O 7 2-328mg (1.02mmol), stirring at room~2h, TLC follows the tracks of (4: 1 n-C 6H 14-AcOEt launches).After reaction is finished, add 10mL H 2O, and with dichloromethane extraction (20mL * 2).Organic layer respectively washs 2 times with water and saturated sodium-chloride water solution, anhydrous sodium sulfate drying, and decompression and solvent recovery, the gained crude product separates (9: 1 n-C through rapid column chromatography 6H 14-AcOEt wash-out), get powdery olefin(e) acid 5b 50mg (31.9% productive rate).
(2) synthetic by 5ba
Figure A20051011126700242
In the 50mL there-necked flask, add above-mentioned 105mg 22-aldehyde 5ba (0.2mmol), the 5mL trimethyl carbinol, stirring makes molten.Add 3mL water, 118mg NaH 2PO 4(0.76mmol), 40mg Resorcinol (0.36mmol) and NaClO 2(80%purity) (72mg, 0.3mmol), stirring at room 0.5~1h, TLC follows the tracks of (3: 1n-C 6H 14-AcOEt launches).After reaction is finished,, respectively wash 2 times through water and saturated sodium-chloride water solution with twice washing of 20mL dichloromethane extraction, anhydrous sodium sulfate drying, decompression and solvent recovery, the gained crude product separates (9: 1 n-C through rapid column chromatography 6H 14-AcOEt wash-out), get powdery olefin(e) acid 5b 91mg (84.1% productive rate).
Compound 5b:
1H-NMR(300MHz,CDCl 3)δ:9.44(d,1H,J=2.1Hz,H-22),7.67(m,4H)and?7.39(m,6H)(phenyls?of?TBDPS),5.60(s,H-16),5.13(d,1H,J=5.1Hz,H-6),3.53(m,1H,H-3),3.12(q,1H,J=6.9Hz,H-20β),1.26(d,3H,J=6.9Hz,H-21),1.06(s,9H,t-butyl?ofTBDPS),1.02(s,3H,H-19),0.81(s,3H,H-18).
Embodiment 16 compound 6b and compound 6c's is synthetic
Figure A20051011126700251
In 50mL egg shape flask, add 40mg olefin(e) acid 5b (0.07mmol), 5mL CH 2Cl 2, stirring makes molten.(70%purity, 0.14mmol), stirring reaction is to (TLC follows the tracks of, 2: 1 n-C fully to add 34mg m-CPBA under the room temperature 6H 14-AcOEt launches).After reaction is finished, remove organic solvent, directly column chromatography for separation is (3: 1: 1n-C 6H 14-AcOEt-AcOH wash-out), gets diepoxy-22-acid 6c 19mg (45.2% productive rate), 16,17-epoxy-22-acid 6b 3mg (7.3% productive rate) and 5,6-epoxy-22-acid 5bb 6mg (14.6% productive rate).
Compound 5bb:
1H-NMR(300MHz,CDCl 3)δ:7.65(m,4H)and?7.38(m,6H)(phenyls?of?TPS),5.58(d,1H,J=3.0Hz,H-16),3.93(m,1H,H-3),3.12(q,1H,J=6.9Hz,H-20β),2.78(dd,1H,J=4.2,7.0Hz,H-6),1.25(d,3H,J=6.0Hz,H-21),1.05(s,9H,tert-butyl?of?TPS),0.88(s,3H,H-19),0.74(s,3H,H-18).
Compound 6b:
1H-NMR(300MHz,CDCl 3)δ:7.65(m,4H)and?7.38(m,6H)(phenyls?of?TBDPS),5.12(d,1H,J=4.8Hz,H-6),3.93(m,1H,H-3),3.34(d,1H,J=4.8Hz,H-16),3.05(q,1H,J=6.9Hz,H-20β),1.21(d,3H,J=7.2Hz,H-21),1.03(s,9H,tert-butyl?of?TBDPS),0.88(s,3H,H-19),0.76(s,3H,H-18).
Compound 6c:
1H-NMR(300MHz,CDCl 3)δ:7.65(m,4H)and?7.36(m,6H)(phenyls?of?TBDPS),3.92(m,1H,H-3),3.36(d,1H,J=4.8Hz,H-16),3.08(q,1H,J=6.9Hz,H-20β),2.74(d,1H,J=4.5Hz,H-6),1.20(d,3H,J=7.2Hz,H-21),1.03(s,9H,tert-butyl?of?TBDPS),0.88(s,3H,H-19),0.78(s,3H,H-18).
Embodiment 17 compound 7b's is synthetic
Figure A20051011126700261
In the 10mL there-necked flask, add 3mg epoxyeicosatrienoic acid 6b (0.005mmol), 1mL dehydrated alcohol, stirring makes molten.Add 2mg LiOHH 2O (0.05mmol) drips 30% hydrogen peroxide 0.5mL, stirs and be warming up to gradually 80 ℃ of reaction 24h down, and TLC follows the tracks of (2: 1 n-C 6H 14-AcOEt launches).After reaction is finished, use saturated NaHSO 3Remove excessive hydrogen peroxide, organic phase is told in acidifying, and with 10mL ethyl acetate extraction water once.Organic phase water and saturated sodium-chloride water solution respectively wash 2 times, anhydrous sodium sulfate drying, and concentrating under reduced pressure, gained oily crude product separates (4: 1 n-C through rapid column chromatography 6H 14-AcOEt wash-out), get lactone 7b 2mg (66.7% productive rate).
Compound 7b:
IR?ν max KBr(cm -1):3477(OH),1758(C=O).
1H-NMR(300MHz,CDCl 3)δ:7.65(m,4H)and?7.38(m,6H)(phenyls?of?TBDPS),5.12(d,1H,J=4.8Hz,H-6),4.51(dd,1H,J=4.8,8.1,H-16α),3.93(m,1H,H-3),2.71(q,1H,J=7.2Hz,H-20β),1.25(d,3H,J=7.2Hz,H-21),1.03(s,9H,tert-butyl?of?TBDPS),0.98(s,3H,H-19),0.87(s,3H,H-18).
EIMS(70eV)m/z(%):598(M +,8),41(100).
HRMS(EI):calcd.for?C 38H 50O 4Si?598.3478,Found?598.3481.
Embodiment 18 compound 7c's is synthetic
Figure A20051011126700262
In the 25mL there-necked flask, add 13mg epoxyeicosatrienoic acid 6c (0.021mmol), 5mL dehydrated alcohol, stirring makes molten.Add 9mg LiOHH 2O (0.21mmol) drips 30% hydrogen peroxide 2mL, stirs and be warming up to gradually 80 ℃ of reaction 24h down, and TLC follows the tracks of (2: 1 n-C 6H 14-AcOEt launches).After reaction is finished, use saturated NaHSO 3Remove excessive hydrogen peroxide, organic phase is told in acidifying, and with 20mL ethyl acetate extraction water once.Organic phase water and saturated sodium-chloride water solution respectively wash 2 times, anhydrous sodium sulfate drying, and concentrating under reduced pressure, gained oily crude product separates (4: 1 n-C through rapid column chromatography 6H 14-AcOEt wash-out), get lactone 7c 9mg (69.2% productive rate).
Compound 7c:
IR?ν max KBr(cm -1):3471(OH),1760(C=O).
1H-NMR(300MHz,CDCl 3)δ:7.63(m,4H)and?7.37(m,6H)(phenyls?of?TBDPS),4.51(dd,1H,J=4.8,8.1,H-16α),3.93(m,1H,H-3),2.77(d,1H,J=4.5Hz,H-6),2.70(q,1H,J=7.2Hz,H-20β),1.21(d,3H,J=7.2Hz,H-21),1.02(s,9H,tert-butyl?of?TBDPS),0.90(s,3H,H-19),0.79(s,3H,H-18).
EIMS(70eV)m/z(%):614(M +,3),41(100).
HRMS(EI):calcd.for?C 38H 50O 5Si?614.3428,Found?614.3424.
Embodiment 19 compound 7d's is synthetic
In the 25mL there-necked flask, add the mixed solvent (v/v 9: 1) of lactone 7a (0.1mmol), 3mL dioxane (dioxane) and the water of the protection of 38mg triatomic ring, stirring makes molten.Add PTSA 10mg, stir and be warming up to gradually 80 ℃ of reaction~4h down, TLC follows the tracks of (1: 2 n-C 6H 14-AcOEt launches).After reaction is finished, use saturated NaHCO 35mL neutralization, and with 10 * 3mL ethyl acetate extraction water.Organic phase water and saturated sodium-chloride water solution respectively wash 2 times, anhydrous sodium sulfate drying, and decompression and solvent recovery, gained oily crude product separates (2: 1 n-C through rapid column chromatography 6H 14-AcOEt wash-out), get powdery 17 alpha-hydroxy-2 2-carboxylic acid lactone 7d 32mg (88.9% productive rate).
Compound 7d:
1H-NMR(300MHz,C 5D 5N)δ:5.36(br.d,1H,J=3.9Hz,H-6),4.87(dd,1H,J=4.7,8.0,H-16α),3.81(m,1H,H-3β),3.05(q,1H,J=7.5Hz,H-20β),2.60(br.d,2H,J=6.9Hz),1.51(d,3H,J=7.5Hz,H-21),1.03(s,3H,H-19),0.91(s,3H,H-18).
13C-NMR(75MHz,C 5D 5N)δ:180.4(s,C-22),141.8(s,C-5),120.7(d,C-6),88.8(s,C-17),86.5(d,C-16),71.1(d,C-3),50.9(d,C-14),50.2(d,C-9),46.5(s,C-13),43.3(t,C-4),40.7(d,C-20),37.7(t,C-1),36.8(s,C-10),32.8(t,C-2),32.4(d,C-8),32.1(t,C-7),32.0(t,C-12),31.8(t,C-15),20.4(t,C-11),19.5(q,C-19),14.2(q,C-18),13.7(q,C-21).
EIMS(70eV)m/z(%):360(M +,30),342(41),327(29),275(41),199(18),159(41),145(68),131(48),119(57),105(93),91(100),79(68),55(61),41(45).
HRMS(EI):calcd.for?C 22H 32O 4360.2301,Found?360.2303.
Embodiment 20 compound 7e's is synthetic
Figure A20051011126700281
In 50mL exsiccant there-necked flask, add 7d 83mg (0.231mmol), the anhydrous CH of 10mL 2Cl 2, stirring makes molten.Add Dess-Martin reagent 147mg (0.346mmol), stirring at room to raw material disappears, and adds 3~5mL 2M NaOH and is stirred to muddy solution becomes clarification.The 60mL ethyl acetate extraction, the ester layer respectively washs 2 times through water and saturated sodium-chloride water solution, anhydrous sodium sulfate drying, decompression and solvent recovery, the gained crude product separates through rapid column chromatography, gets 17 alpha-hydroxy-2 2-carboxylic acid lactone 7e 73mg (88.4% productive rate).
Compound 7e:
1H-NMR(300MHz,CDCl 3)δ:5.93(s,1H,H-4),4.37(dd,1H,J=4.8,8.1,H-16α),1.21(d,3H,J=7.5Hz,H-21),1.19(s,3H,H-19),1.01(s,3H,H-18).
EIMS(70eV)m/z(%):358(M +,19),340(35),105(100).
HRMS(EI):calcd.for?C 22H 30O 4358.2144,Found?358.2141.
Embodiment 21 compound 7f's is synthetic
In 25mL exsiccant there-necked flask, add 11mg lactone 7b (0.018mmol), add the 5mL chloroform, stirring makes molten.Ice bath drips 3mg Br down 21mL CCl (0.019mmol) 4Solution.TLC follows the tracks of reaction to fully, adds saturated Na 2SO 3Remove excessive bromine, add the 50mL chloroform, tell chloroform layer after the jolting a little, be washed to neutrality with water and saturated common salt successively, anhydrous sodium sulfate drying, concentrating under reduced pressure, rapid column chromatography separates, and gets 5 α, 6 beta-2-dibroms-17-Alpha-hydroxy-lactone 7f 12mg (86.3% productive rate).
Compound 7f:
1H-NMR(300MHz,CDCl 3)δ:7.63(m,4H)and?7.36(m,6H)(phenyls?of?TBDPS),4.50(dd,1H,J=4.8,8.1,H-16α),.3.90(m,1H,H-3),3.85(br?s,1H,H-6),1.21(d,3H,J=7.2Hz,H-21),1.03(s,9H,tert-butyl?of?TBDPS),0.98(s,3H,H-19),0.87(s,3H,H-18).
EIMS(70eV)m/z(%):598(18),41(100).
EA:calcd.C?60.16,H?6.64;Found?C?60.08,H?6.69.

Claims (7)

1, a class C22 steroidal compounds is characterized in that having following structural formula:
Figure A2005101112670002C1
Wherein
Figure A2005101112670002C2
Or
Y is H 2Perhaps O; R 1Be H, OH, OMOM, OBn, OTHP, OAc, OMs, OTs, OBz, OPiv, OTMS, OTES, OTBS or OTBDPS; R 2Be H, OH, OMOM, OBn, OTHP, OAc, OMs, OTs, OBz, OPiv, OTMS, OTES, OTBS, OTBDPS or X; R 3Be H, OH, OMOM, OBn, OTHP, OAc, OMs, OTs, OBz, OPiv, OTMS, OTES, OTBS, OTBDPS or X; Perhaps R 2And R 3Become carbonyl; R 4Be H, OH, OMe, OEt, OMOM, OBn, OTHP, OAc, OMs, OTs, OBz, OPiv, OTMS, OTES, OTBS, OTBDPS or X; R 5Be OH, OTMS or X; R 6Be OH, OMs, OTs or X; Perhaps R 5And R 6Become 16, the two keys of 17-; R 7Be H, OH or X; Perhaps R 5And R 7Become 16, the 17-epoxy; R 8For H, OH,, OMe, OEt, OMOM, OBn, OTHP, OAc, OMs, OTs, OBz, OPiv, OTMS, OTES, OTBS, OTBDPS or X; Perhaps R 6And R 8Become oxo bridge;
When Y is O, R 7Be H, R 6And R 8Become oxo bridge, R 3Be H, and R 4During for H, R 2Can not be H, OH, OMOM, OAc, OTBS, OTBDPS or X;
Wherein, MOM is a methoxyl methyl, and Bn is a benzyl; THP is a THP trtrahydropyranyl, and Ac is an ethanoyl, and Ms is a methylsulfonyl; Ts is a p-toluenesulfonyl; Bz is a benzoyl, and Piv is a pivaloyl group, and TMS is trimethyl silicon based; TES is that triethyl is silica-based; TBS is that tertiary butyl dimethyl is silica-based, and TBDPS is that tert-butyl diphenyl is silica-based, and X is a halogen.
2, a class C22 steroidal compounds as claimed in claim 1 is characterized in that having following structural formula:
Figure A2005101112670003C1
Figure A2005101112670003C2
The definition of each group according to claim 1, Ac is an ethanoyl.Wherein, in the compound 7, work as R 2Be H and R 3During for H,
Figure A2005101112670003C3
Can not for Or
Figure A2005101112670003C5
3, a class C22 steroidal compounds as claimed in claim 1 is characterized in that having following structural formula:
Figure A2005101112670004C1
Figure A2005101112670004C2
4, the synthetic method of a class C22 steroidal compounds as claimed in claim 1 is characterized in that using respectively method 1), 1)-2), 1)-3), 1)-4), 1)-5), 1)-6) or 1)-7) come synthetic:
1): compound 1 is dissolved in the aprotic solvent, adds reductive agent (0.5 equivalent-3 equivalent) ,-78 ℃ were reacted 0.5 hour to 24 hours to the temperature that refluxes, get compound 2; Described reductive agent can be NaBH 4, NaBH 3CN, KBH 4, LiBH 4, LiAlH 4Perhaps diisobutyl aluminium hydride.
2): compound 2 is dissolved in the organic solvent, adds diacetyl oxide or Acetyl Chloride 98Min. (0.5 equivalent-6 equivalent) ,-78 ℃ were reacted 0.5 hour to 24 hours to reflux temperature; Add SULPHURYL CHLORIDE (1 equivalent-6 equivalent) then, heat to make in 0.5 hour to 24 hours and react completely, compound 3; Described organic solvent is non-protonic solvent, nitrogenous organic base or their mixed solvent; Described sulfonic acid acyl chlorides can be methylsulfonyl chloride, Tosyl chloride or trifluoromethanesulfchloride chloride.
3): compound 3 is dissolved in the polar solvent, and adding removes protecting group reagent (1 equivalent-6 equivalent), and-78 ℃ were reacted 0.5 hour to 24 hours to reflux temperature, get compound 4; Removing protecting group reagent can be to comprise the monovalence of sodium bicarbonate, saleratus, yellow soda ash, salt of wormwood, cesium carbonate, lime carbonate, lithium hydroxide, sodium hydroxide, potassium hydroxide, calcium hydroxide or oxyhydroxide, carbonate or the supercarbonate of divalent metal.
4): compound 4 is dissolved in the organic solvent, adds oxygenant (1 equivalent-9 equivalent) ,-78 ℃ were reacted 0.5 hour to 72 hours to reflux temperature, get compound 5; Wherein, recommending organic solvent can be dimethyl formamide, hexamethylphosphoramide, the trimethyl carbinol or methylene dichloride; Oxygenant can be Manganse Dioxide, potassium manganate, potassium permanganate, chromic anhydride, Sodium chromate, chromic acid pyridinium salt, clorox, Textone or potassium chlorite.
5): compound 5 is dissolved in the non-protonic solvent, adds epoxidation reagent (1 equivalent-6 equivalent) ,-78 ℃ were reacted 0.5 hour to 6 hours to reflux temperature, get compound 6; Epoxidation reagent can be Peracetic Acid, metachloroperbenzoic acid, hydrogen peroxide, peroxy trifluoroacetic acid or peroxy propanone.
6): compound 6 is dissolved in the organic solvent, adds appropriate bases (1 equivalent-9 equivalent) and hydrogen peroxide (0.5 equivalent-10 equivalent), reaction is 0.5 hour to 24 hours under 0 ℃ of-90 ℃ of temperature, gets compound 7; Recommending organic solvent can be alcoholic solvent, acetone or tetrahydrofuran (THF); Alkali can be oxyhydroxide, carbonate, supercarbonate, acetate or nitrogenous organic base.
5, the synthetic method of a class C22 steroidal compounds as claimed in claim 3 is characterized in that described non-protonic solvent is CH 2Cl 2, CHCl 3, CCl 4, tetrahydrofuran (THF) or ether.
6, the synthetic method of a class C22 steroidal compounds as claimed in claim 3 is characterized in that described polar solvent is acetone, acetonitrile, methyl alcohol, ethanol, propyl alcohol, Virahol, butanols, the trimethyl carbinol, CH 2Cl 2, CHCl 3Or water.
7, the synthetic method of a class C22 steroidal compounds as claimed in claim 3, it is characterized in that described nitrogenous organic base is 1,8-diazabicylo [5,4,0] 11-7-alkene, pyridine, 4-Dimethylamino pyridine, bipyridine, lutidine, trimethylpyridine or have C 1-18The primary amine of alkyl, secondary amine or tertiary amine.
CNB2005101112679A 2005-12-08 2005-12-08 C22 steroid compounds and their synthesizing method Active CN100358913C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005101112679A CN100358913C (en) 2005-12-08 2005-12-08 C22 steroid compounds and their synthesizing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005101112679A CN100358913C (en) 2005-12-08 2005-12-08 C22 steroid compounds and their synthesizing method

Publications (2)

Publication Number Publication Date
CN1775799A true CN1775799A (en) 2006-05-24
CN100358913C CN100358913C (en) 2008-01-02

Family

ID=36765535

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005101112679A Active CN100358913C (en) 2005-12-08 2005-12-08 C22 steroid compounds and their synthesizing method

Country Status (1)

Country Link
CN (1) CN100358913C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100362013C (en) * 2006-03-16 2008-01-16 中国科学院上海有机化学研究所 C22 carbanyl steroid compound, synthetic method and its use
CN102856431A (en) * 2012-08-12 2013-01-02 安阳市凤凰光伏科技有限公司 Method for treating residual glue of solar cell fragments

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1120844C (en) * 2000-12-22 2003-09-10 中国科学院上海有机化学研究所 Lactone compound and its synthesis and use
CN1273481C (en) * 2004-06-04 2006-09-06 中国科学院上海有机化学研究所 17 alpha, 22-dicarboxy furo compound and its use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100362013C (en) * 2006-03-16 2008-01-16 中国科学院上海有机化学研究所 C22 carbanyl steroid compound, synthetic method and its use
CN102856431A (en) * 2012-08-12 2013-01-02 安阳市凤凰光伏科技有限公司 Method for treating residual glue of solar cell fragments

Also Published As

Publication number Publication date
CN100358913C (en) 2008-01-02

Similar Documents

Publication Publication Date Title
CN1033809C (en) Novel a-nor-steroid-3-carboxylic acid derivatives
CN1177857C (en) Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the prepararation of the derivatives
CN1067976C (en) Asiatic acid derivatives its manufacturing method and dermatological agent containing it
CN1042026C (en) 25Carboxylic derivative of vitamin D series, middle products in production of same and pharmaceutical containing same and use of same in treatment
CN101048394A (en) Semi-synthetic conversion of paclitaxel to docetaxel
CN1349534A (en) 6-alkenyl-, 6-alkinyl-and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
CN1071917A (en) Quinazoline derivant as human immunodeficiency virus reversed transcriptive enzyme antagonist
CN1599738A (en) Urea substituted imidazopyridines
CN1090581A (en) The preparation method of the novel derivative of erythromycin and they and as the application of medicine
CN1127753A (en) New imidazolidines substituted by a heterocycle, their preparation process and intermediates, their use as medicaments NAD the pharmaceutical compositions containing them
CN1240380C (en) Phase transfer catalyzed glycosidation of an indolocarbazole
CN1299359A (en) Benzofurylpyrone derivatives
CN101028263A (en) Use of substituted isoandrographolide derivative
CN1106368A (en) Triterpene derivatives and endothelin-receptor antagonists containing the same
CN1235887C (en) Preparation method of isoxazolylalkyldione compound
CN1876658A (en) Gambogicacid derivative and its preparation method and uses in pharmacy
CN1775799A (en) C22 steroid compounds and their synthesizing method
CN1383427A (en) Process for preparing N6-substituted deaza-adenosine derivatives
CN1164577C (en) Process for preparing 2-amino-4-(4-fluorophenyl)-6-alkylpyrimidine-5-carboxylate
CN1461301A (en) Benzo [b] thiophene derivative and process for producing the same
CN1243746C (en) Heterocyclic compound inhibiting angiogenesis
CN1539831A (en) Taxad alkyl derivative and its prepn. process
CN1042354A (en) (RS)-and 2-(2,3-dihydro-5-hydroxyl-4,6,7-trimethylbenzene benzofuryl) acetate and 2-2,3-dihydro-5-acetoxyl group-4,6,7-trimethylammonium benzofuryl) acetate and ester thereof, as mucus conditioning agent and anti-hyschaemic medicine and preparation method thereof
CN1303096C (en) Process for preparing corosolic acid and crataegolic acid
CN1026785C (en) Process for preparing clausenamide and neoclausenamide, and of their derivatives

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant